In Focus
Editorials
- Risk factors for rare diseases can be risky to definePML and natalizumabEugene O. Major, Daniel C. Douek
- Cocoa, neurovascular coupling, and neurodegenerationThe good, the bad, and the uglyPaul B. Rosenberg, Can Ozan Tan
Articles
- l-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patientsNicholas Schwab, Tilman Schneider-Hohendorf, Vilmos Posevitz, Johanna Breuer, Kerstin Göbel, Susanne Windhagen, Bruno Brochet, Patrick Vermersch, Christine Lebrun-Frenay, Anita Posevitz-Fejfár, Ruggero Capra, Luisa Imberti, Vera Straeten, Juergen Haas, Brigitte Wildemann, Joachim Havla, Tania Kümpfel, Ingrid Meinl, Kyle Niessen, Susan Goelz, Christoph Kleinschnitz, Clemens Warnke, Dorothea Buck, Ralf Gold, Bernd C. Kieseier, Sven G. Meuth, John Foley, Andrew Chan, David Brassat, Heinz Wiendl
- Immune competence after alemtuzumab treatment of multiple sclerosisClaire L. McCarthy, Orla Tuohy, D. Alastair S. Compston, Dinakantha S. Kumararatne, Alasdair J. Coles, Joanne L. Jones
- Comment: Assessing humoral immunocompetence after alemtuzumab treatment in MSAnne H. Cross, Robyn S. Klein
- Retinal periphlebitis is associated with multiple sclerosis severitySantiago Ortiz-Pérez, Elena H. Martínez-Lapiscina, Iñigo Gabilondo, Elena Fraga-Pumar, Eloy Martínez-Heras, Albert Saiz, Bernardo Sanchez-Dalmau, Pablo Villoslada
- GABAB receptor autoantibody frequency in service serologic evaluationOliver J. Jeffery, Vanda A. Lennon, Sean J. Pittock, Jeremy K. Gregory, Jeffrey W. Britton, Andrew McKeon
- Antihypertensive medication use and risk of cognitive impairmentThe Honolulu-Asia Aging StudyRebecca P. Gelber, G. Webster Ross, Helen Petrovitch, Kamal H. Masaki, Lenore J. Launer, Lon R. White
- Antihypertensive drugs decrease risk of Alzheimer diseaseGinkgo Evaluation of Memory StudySevil Yasar, Jin Xia, Wenliang Yao, Curt D. Furberg, Qian-Li Xue, Carla I. Mercado, Annette L. Fitzpatrick, Linda P. Fried, Claudia H. Kawas, Kaycee M. Sink, Jeff D. Williamson, Steven T. DeKosky, Michelle C. Carlson, For the Ginkgo Evaluation of Memory (GEM) Study Investigators
- Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older peopleFarzaneh A. Sorond, Shelley Hurwitz, David H. Salat, Douglas N. Greve, Naomi D.L. Fisher
- Risk of incident stroke in patients with Alzheimer disease or vascular dementiaPatrick Imfeld, Michael Bodmer, Markus Schuerch, Susan S. Jick, Christoph R. Meier
- MRI-identified pathology in adults with new-onset seizuresTahir Hakami, Anne Mcintosh, Marian Todaro, Elaine Lui, Raju Yerra, K. Meng Tan, Chris French, Simon Li, Patricia Desmond, Zelko Matkovic, Terence J. O'Brien
Global Perspectives
Clinical/Scientific Notes
- Diagnostic challenge and therapeutic dilemma in necrotizing myopathyKristl G. Claeys, Olga Gorodinskaya, Susanne Handt, Jens Reimann, Wolfram Kress, Cornelia Kornblum, Christiane Kuhl, Jörg B. Schulz, Joachim Weis
NeuroImages
- Multiple intraventricular neurocysticerciDeepti Vibha, Vipin Ola, Madhuri Behari, Vinay Goyal, Garima Shukla, S. Leve Joseph Devarajan
Resident and Fellow Section
- Clinical Reasoning: A 40-year-old man with CIDP-like illness resistant to treatmentRajat Lahoria, Chafic Karam, Angela Dispenzieri, P. James B. Dyck
- Teaching NeuroImages: Awakening ptosis (unilateral hypnopompic eyelid palsy)Giacomo Della Marca, Anna Losurdo, Susanna Cordone, Fabio Pilato, Paolo Profice, Elisa Testani, Vincenzo Di Lazzaro
- Teaching NeuroImages: Methotrexate neurotoxicityResolution and evolution of MRI changes within 48 hoursSaad Kanaan, Karan Poddar, Yu-Tze Ng
WriteClick: Editor’s Choice
- Prehospital thrombolysis in acute stroke: Results of the PHANTOM-S pilot studyTabish A. Saifee, Christian M. Burd, Cristina Koppel
- Neighborhood socioeconomic status and stroke mortality: Disentangling individual and area effectsAuthor ResponseManoj K. Mittal, Luciano A. Sposato, Jennifer B. McCormick, Olivier Grimaud
Advertisement
Popular on
Neurology

Advertisement